Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules
Authors:
- Sachin S. KadamSKSachin S. Kadam
- M. SudhakarMSM. Sudhakar
- Prabha D. NairPNPrabha D. Nair
- Ramesh R. BhondeRBRamesh R. Bhonde
- 1 December 2010
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 12 (8) , 982-991
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Directed engineering of umbilical cord blood stem cells to produce C‐peptide and insulinCell Proliferation, 2007
- Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structureBiochemical and Biophysical Research Communications, 2007
- Type 1 diabetesThe Lancet, 2006
- Global Prevalence of DiabetesDiabetes Care, 2004
- In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cellsProceedings of the National Academy of Sciences, 2002
- Science, medicine, and the future: Islet and stem cell transplantation for treating diabetesBMJ, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- In vitro cultivation of human islets from expanded ductal tissueProceedings of the National Academy of Sciences, 2000
- Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cellsNature Medicine, 2000
- Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.Diabetes, 2000